Infantile autism: a dysfunction of the opioids?
Related Experiment Videos
Medical Hypotheses
|January 1, 1986
Abstract:
We postulate that infantile autism may be caused by a disorder of the endogenous opioid system. Evidence is provided linking the features of this condition with opiatergic dysfunction.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.
The Cochrane database of systematic reviews·2007
Antidepressants are not drugs of abuse or dependence.
Postgraduate medical journal·1999
Clinical role and mechanisms of action of analgesic nitrous oxide.
The International journal of neuroscience·1998
Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.
Clinical neuropharmacology·1996
Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco.
The International journal of neuroscience·1994
Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state.
The International journal of neuroscience·1994
Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?
Medical hypotheses·2025
How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?
Medical hypotheses·2024
Unstable Plaque is a Treatable Cause of Cognitive Decline.
Medical hypotheses·2024
Opioid Analgesic Exposure and Mental Health Disorders During Pregnancy: Exploring Their Independent and Joint Association With Adverse Birth Outcomes.
Paediatric and perinatal epidemiology·2026
Autism spectrum disorder and mild traumatic brain injury in the pediatric population: a scoping review.
Journal of neurosurgery. Pediatrics·2026
Evaluation of Context-Specific Early Identification of Autism Models Involving Multiple Stakeholders: Examples From Three Areas of England.
Journal of autism and developmental disorders·2026
Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective.
Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2026